Recycling a tragedy

Lee, Sophia
October 2015
World (0888157X);10/3/2015, Vol. 30 Issue 20, p46
The article discusses the infectious disease HIV or AIDS, method of diagnosis, and treatment.


Related Articles

  • Undiagnosed HIV infection in patients with viral hepatitis. Geretti, Anna Maria; Madge, Sara; Posner, Marcus; Dusheiko, Geoff; Jacobs, Michael // BMJ: British Medical Journal (International Edition);6/28/2008, Vol. 336 Issue 7659, p1451 

    A letter to the editor is presented which discusses a study regarding the diagnosis of HIV infection in viral hepatitis patients.

  • Complementary HIV/AIDS therapies to be offered at six new sites.  // Gay & Lesbian Times;6/24/2004, Issue 861, p23 

    Announces the availability of the complementary HIV/AIDS therapies at sites in San Diego area, California.

  • Decision-Making Therapy in HIV/AIDS: The African Experience. Nwoye, Augustine // Dialectical Anthropology;2004, Vol. 28 Issue 3/4, p377 

    The challenge of providing relevant and sophisticated counseling interventions to people with HIV/AIDS in Africa has greatly intensified. The task has shifted from what it was deemed to entail at the first decade of the disease. Then, it was understood to involve the process of bringing healing...

  • State AIDS Drug Assistance Programs Continue to Face Difficult Funding Challenges; 11 States Close Enrollment, 9 Have Waiting Lists to Receive HIV Drugs; Wide Variation in Access to HIV...  // Ascribe Newswire: Medicine;5/21/2004, p154 

    Despite a 9 percent increase in the overall AIDS Drug Assistance Programs (ADAP) budget in the U.S. between fiscal year 2002 and 2003, an increasing number of people living longer with HIV/AIDS, the rising costs of HIV medications, and continuing fiscal pressures at the Federal and state levels...

  • Living With The Enemy: Never Letting Our Guard Down. Murray, Jeffrey S. // FDA Consumer;Nov/Dec2001, Vol. 35 Issue 6, p40 

    Comments on the treatment of HIV and AIDS. Difference of the treatment of HIV with other chronic illnesses; First step in dealing with HIV battle fatigue; Characteristics of drugs that are in urgent search for treating HIV.

  • Behind the Headlines: Is a cure for AIDS in sight? Baines, Emma // GP: General Practitioner;11/25/2005, p20 

    The article presents information on a case study related to AIDS. It discusses an incident when a person miraculously recovered from this disease. According to media reports a man who has miraculously recovered from HIV may hold the secret to curing AIDS. The papers said that 25-year-old Andrew...

  • The Search for Data on When to Start Treatment for HIV Infection. Hughes, Michael D.; Ribaudo, Heather R. // Journal of Infectious Diseases;4/15/2008, Vol. 197 Issue 8, p1034 

    The author presents the data gathered by the Strategies for Management of Antiretroviral Therapy (SMART) which are relevant to the potential application of antiretroviral therapy (ART) for infection with HIV. The study reveals that HIV-infected subjects who immediately initiated ART have...

  • Free Fluconazole for Cryptococcal Meningitis: Too Little of a Good Thing? Hamill, Richard J. // Clinical Infectious Diseases;10/15/2006, Vol. 43 Issue 8, p1074 

    The article comments on the results of a comparison between amphotericin B and fluconazole and concluded that fluconazole is an effective alternative to amphotericin B as primary treatment of cryptococcal meningitis in patients with AIDS. The introduction of HAART agents contributed to the...

  • Experimental Drugs: The Personal Dimension. Helquist, Michael // Advocate;8/30/88, Issue 506, p40 

    Reports on experimental drugs for AIDS and HIV infections, as discussed by William Woods in the May 1988 issue of 'Focus: A Guide to AIDS Research.' Offer of guidelines to help counselors and their clients discuss whether to take experimental drugs; Contact information.

  • Identification, management, and prevention of adverse effects associated with highly active antiretroviral therapy. Schiller, Daryl S. // American Journal of Health-System Pharmacy;12/1/2004, Vol. 61 Issue 23, p2507 

    Focuses on the identification, management and prevention of adverse effects associated with highly active antiretroviral therapy to treat HIV infections. Options for the management of the complications; Requirement for a number of drug regimens; Disadvantage of adverse effects.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics